Internal link ProQR Therapeutics Virtual R&D Event 2023 Webcast On March 29, 2023 ProQR will host a virtual R&D event to showcase its proprietary Axiomer RNA-editing technology platform. ProQR will also announce initial pipeline targets for internal development. Add ProQR Therapeutics Virtual R&D Event 2023 to calender Investor Mar 29 2023 10:00 AM EDT
Internal link Oligonucleotide and Precision Therapeutics (OPT) Congress Congress ProQR presentation and panel session at the Oligonucleotide and Precision Therapeutics (OPT) Congress Add Oligonucleotide and Precision Therapeutics (OPT) Congress to calender Research Mar 14 2023
Internal link ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview Webcast With the announcement of the expansion of ProQR and Lilly's partnership, ProQR Management is hosting a conference call. Add ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview to calender Investor Dec 22 2022 8:15 AM EST/14:15 CET
Internal link TIDES Europe - Oligonucleotide and Peptide Therapeutics Conference Congress ProQR to present at the TIDES Europe conference on oligonucleotide and peptide therapeutics in Vienna, Austria and online. Add TIDES Europe - Oligonucleotide and Peptide Therapeutics Conference to calender Research Nov 16 2022 to 18 Nov
Internal link Investor Call Webcast ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs - Management Call Add Investor Call to calender Investor Aug 11 2022 8:15 AM EDT/14:15 CET